Serum sphingolipidomic analyses reveal an upregulation of C16- ceramide and sphingosine-1-phosphate in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Serum sphingolipidomic analyses reveal an upregulation of C16- ceramide and sphingosine-1-phosphate in hepatocellular carcinoma

Published:2016-02-26 Issue:14 Volume:7 Page:18095-18105
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Grammatikos Georgios¹²,Schoell Niklas²,Ferreirós Nerea³,Bon Dimitra⁴,Herrmann Eva⁴,Farnik Harald²,Köberle Verena²,Piiper Albrecht²,Zeuzem Stefan²,Kronenberger Bernd²,Waidmann Oliver²,Pfeilschifter Josef¹

Affiliation:

1. Goethe University Hospital, Pharmazentrum Frankfurt, Institut für Allgemeine Pharmakologie und Toxikologie, Frankfurt am Main, Germany

2. Goethe University Hospital, Medizinische Klinik 1, Frankfurt am Main, Germany

3. Pharmazentrum Frankfurt, Institut für klinische Pharmakologie, Goethe University Hospital, Frankfurt am Main, Germany

4. Goethe University, Department of Medicine, Institute of Biostatistics and Mathematical Modelling, Frankfurt am Main, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ceramides are fuel gauges on the drive to cardiometabolic disease;Physiological Reviews;2024-07-01

2. Application of Graph Models to the Identification of Transcriptomic Oncometabolic Pathways in Human Hepatocellular Carcinoma;Biomolecules;2024-06-03

3. Application of graph models to the identification of transcriptomic oncometabolic pathways in human hepatocellular carcinoma;2024-05-02

4. Critical Roles of the Sphingolipid Metabolic Pathway in Liver Regeneration, Hepatocellular Carcinoma Progression and Therapy;Cancers;2024-02-20

5. Tolypothrix Dichloromethane Ethylacetate fraction (TDEF) inhibits cisplatin resistance H357 cell through PI3K/AKT/beta-catenin pathway;American Journal of Cancer Research;2024